Table 2.
Multivariate analysis of RECQL5 mRNA expression in breast cancer
| P Value | Risk ratio | 95% CI for risk ratio | ||
|---|---|---|---|---|
| Lower | Upper | |||
| BCSS (whole cohort) | ||||
| Grade | 0.000004 | 1.447429 | 1.237421 | 1.693079 |
| Size (cm) | 0.000001 | 1.121003 | 1.076755 | 1.167069 |
| LN status | 0.000001 | 1.875371 | 1.666800 | 2.110040 |
| RECQL5 mRNA expression | 0.023530 | 1.223718 | 1.027549 | 1.457337 |
| BCSS (ER± cohort) | ||||
| Grade | 0.0002 | 1.411263 | 1.176981 | 1.692178 |
| Size (cm) | 0.000001 | 1.180525 | 1.123389 | 1.240566 |
| LN status | 0.000001 | 1.822326 | 1.578493 | 2.103825 |
| RECQL5 mRNA expression | 0.045 | 1.242008 | 1.004707 | 1.535359 |
| BCSS (ER− cohort) | ||||
| Grade | 0.968564 | 1.008054 | 0.676448 | 1.502217 |
| Size (cm) | 0.239188 | 1.046124 | 0.970452 | 1.127695 |
| LN status | 0.000001 | 1.908038 | 1.539252 | 2.365181 |
| RECQL5 mRNA expression | 0.635591 | 1.078023 | 0.790092 | 1.470886 |
Bold: statistically significant; CI, confidence interval; HR, hazard ratio; LN, lymph node.